Ag-221, an oral, selective, first-in-class, potent inhibitor of the IDH2 mutant enzyme, induced durable responses in a phase 1 study of IDH2 mutation-positive advanced hematologic malignancies Meeting Abstract


Authors: DiNardo, C.; Stein, E. M.; Altman, J. K.; Collins, R.; DeAngelo, D. J.; Fathi, A. T.; Flinn, I.; Frankel, A.; Levine, R. L.; Medeiros, B. C.; Patel, M.; Pollyea, D. A.; Roboz, G. J.; Stone, R. M.; Swords, R. T.; Tallman, M. S.; Almon, C.; Fan, B.; Goldwasser, M.; Yen, K.; Attar, E.; de Botton, S.
Abstract Title: Ag-221, an oral, selective, first-in-class, potent inhibitor of the IDH2 mutant enzyme, induced durable responses in a phase 1 study of IDH2 mutation-positive advanced hematologic malignancies
Meeting Title: 20th Congress of the European Hematology Association (EHA)
Journal Title: Haematologica
Volume: 100
Issue: Suppl. 1
Meeting Dates: 2015 Jun 11-14
Meeting Location: Vienna, Austria
ISSN: 0390-6078
Publisher: Ferrata Storti Foundation  
Date Published: 2015-06-01
Start Page: 216
End Page: 217
Language: English
ACCESSION: WOS:000361204902073
PROVIDER: wos
PMCID: PMC4480587
Notes: Meeting Abstract: P569 -- Source: Wos
MSK Authors
  1. Eytan Moshe Stein
    342 Stein
  2. Martin Stuart Tallman
    649 Tallman
  3. Ross Levine
    775 Levine
Related MSK Work